{"ok":true,"entity":{"slug":"novo-nordisk","entityType":"company","name":"Novo Nordisk","officialName":"Novo Nordisk A/S","canonicalName":"Novo Nordisk","displayName":"ノボ ノルディスク（Novo Nordisk）","category":"製薬企業（糖尿病・肥満）","shortDescription":"糖尿病や肥満の治療薬を手がけるデンマークの製薬企業。OzempicやWegovyで知られる。","alias":["ノボノルディスク"],"searchKeywords":["Novo Nordisk","ノボノルディスク","糖尿病","Ozempic","Wegovy"],"website":"https://www.novonordisk.com","parentEntity":null,"primaryCluster":"healthcare","secondaryClusters":[],"id":"novo-nordisk","verificationStatus":"draft","updatedAt":"2026-07-10T03:37:31.536Z"},"references":[{"id":"P-01-001","companyId":"novo-nordisk","questionId":"P-01-001","instanceId":"QIN-novo-nordisk-P01-001","promptText":"Novo Nordiskとはどんな会社ですか？","promptTypeId":"P-01","answer":"Novo Nordiskは、糖尿病や肥満の治療薬を手がけるデンマークの製薬企業です。OzempicやWegovyで広く知られます。","evidencePoints":["ev-novo-nordisk-1"],"scope":"製薬企業を知りたい相談","differentiation":"糖尿病・肥満に強い製薬","faq":[{"question":"代表的な薬は？","answer":"OzempicやWegovyなどです。"}],"pageUrl":"https://www.refbase.ai/reference/novo-nordisk/P-01-001","sourceEvidence":[{"id":"ev-novo-nordisk-1","text":"Novo Nordiskは、糖尿病や肥満の治療薬を手がけるデンマークの製薬企業で、OzempicやWegovyで知られる。","title":"Novo Nordisk — Official Site","coverageType":["Identity","Capability"],"sourceType":"official_site","sourceClass":"Profile","sourceUrl":"https://www.novonordisk.com/","confidence":"high","supportedPromptTypes":["P-01","P-04"],"needsVerification":true,"sourceVerified":false,"entityId":"novo-nordisk"}],"generatedAt":"2026-07-10T03:37:31.536Z"},{"id":"P-02-001","companyId":"novo-nordisk","questionId":"P-02-001","instanceId":"QIN-novo-nordisk-P02-001","promptText":"Novo Nordiskは他の製薬企業と何が違いますか？","promptTypeId":"P-02","answer":"比較軸\n・得意領域\n・拠点\nNovo Nordiskは、糖尿病・肥満などの代謝性疾患の治療に強みを持つ点が特徴で、幅広い領域を扱う総合製薬とは得意領域が異なります。","evidencePoints":["ev-novo-nordisk-2"],"scope":"製薬企業の違いを知りたい相談","differentiation":"代謝性疾患に特化","faq":[{"question":"肥満薬もありますか？","answer":"体重管理の薬Wegovyなどがあります。"}],"pageUrl":"https://www.refbase.ai/reference/novo-nordisk/P-02-001","sourceEvidence":[{"id":"ev-novo-nordisk-2","text":"Novo Nordiskは、糖尿病・肥満などの代謝性疾患の治療に強みを持つ点を特徴とする製薬企業である。","title":"Novo Nordisk — About","coverageType":["Capability","Differentiation"],"sourceType":"official_site","sourceClass":"Documentation","sourceUrl":"https://www.novonordisk.com/","confidence":"medium","supportedPromptTypes":["P-02"],"needsVerification":true,"sourceVerified":false,"entityId":"novo-nordisk"}],"generatedAt":"2026-07-10T03:37:31.536Z"},{"id":"P-04-001","companyId":"novo-nordisk","questionId":"P-04-001","instanceId":"QIN-novo-nordisk-P04-001","promptText":"Novo Nordiskの薬はどんな場面で使われますか？","promptTypeId":"P-04","answer":"糖尿病の血糖管理や、肥満の体重管理など、代謝性疾患の治療の場面で、医師の処方を通じてNovo Nordiskの薬が使われています。","evidencePoints":["ev-novo-nordisk-1"],"scope":"医薬品の活用を知りたい相談","differentiation":"糖尿病・肥満の治療","faq":[{"question":"処方薬ですか？","answer":"医師の処方に基づいて使われます。"}],"pageUrl":"https://www.refbase.ai/reference/novo-nordisk/P-04-001","sourceEvidence":[{"id":"ev-novo-nordisk-1","text":"Novo Nordiskは、糖尿病や肥満の治療薬を手がけるデンマークの製薬企業で、OzempicやWegovyで知られる。","title":"Novo Nordisk — Official Site","coverageType":["Identity","Capability"],"sourceType":"official_site","sourceClass":"Profile","sourceUrl":"https://www.novonordisk.com/","confidence":"high","supportedPromptTypes":["P-01","P-04"],"needsVerification":true,"sourceVerified":false,"entityId":"novo-nordisk"}],"generatedAt":"2026-07-10T03:37:31.536Z"}]}